mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer
Clinical trial NCT03043729 · COMPLETED
Trial details
- NCT number
- NCT03043729
- Sponsor
- AIO-Studien-gGmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-06
- Primary completion
- 2021-01-11
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.